Atossa Therapeutics Inc (NASDAQ:ATOS) ended slightly lower on Friday.
On Friday, ATOS stock fell 0.62% to end the session at $3.23. More than 11.57 million shares exchanged hands for the day, compared to its average volume of 1.57 million shares. The stock opened at $3.26 and moved within a range of $3.2000 – 3.3950.
Physician-Scientist Dr. Steven Quay to Brief the U.S. Congress On His Research Investigating the Origin of the COVID-19 Pandemic
- Physician-Scientist Dr. Steven C. Quay, M.D., Ph.D., CEO of Atossa Therapeutics (NASDAQ: ATOS) has been asked to brief the elected members and staff of the United States Congress on his work on the origin of the COVID-19 pandemic.
- The virtual meeting will take place from 2:00 to 3:30 pm EDT, Monday, May 24, 2021. Dr. Quay will speak about his research on the origin of the pandemic, which he published in January 2021 and which is available here.
- In this analysis he concludes that it is beyond a reasonable doubt the virus came from a laboratory accident, a so called “laboratory-acquired infection”, in Wuhan, China.
|SHARES OUTSTANDING||120.82 M|
|SHARE FLOAT (%)||120.80 M (99.98%)|
|% HELD BY INSTITUTIONS||12.05|
Recent Stock Performance
|+/- EMA(20)||2.71 (+19.19%)|
|+/- SMA(50)||2.33 (+38.63%)|
|+/- SMA(200)||2.19 (+47.49%)|
|CCI20||124.4741||Buy||Chaikin Money Flow||-0.0167||Neutral|
|MACD||0.2612||Buy||Money Flow Index||73.7075||Buy|
|STOCH (14,3)||84.8000||OverBought||STOCH RSI||0.9376||OverBought|